Tianjiao Dang
Harbin, 150001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Elevated CHAF1A suppresses type I interferon production and causes immunotherapy resistance in esophageal squamous cell carcinoma.
Journal: Cancer immunology research
Published: December 21, 2025
IL-17A blockade alleviates immune checkpoint inhibitor-associated psoriasiform rash: preclinical and clinical responses.
Journal: Cancer biology & medicine
Published: October 13, 2025
Targeting CTGF overcomes resistance to CSF1R inhibitors by preventing CAF activation in colorectal cancer.
Journal: Cell reports. Medicine
Published: March 26, 2025
Multiomics Reveals the Immunologic Features and the Immune Checkpoint Blockade Potential of Colorectal Medullary Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 01, 2024
Colorectal medullary carcinoma: a pathological subtype with intense immune response and potential to benefit from immune checkpoint inhibitors.
Journal: Expert review of clinical immunology
Published: March 09, 2024
Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD-mediated pyroptosis in colorectal cancer.
Journal: Clinical and translational medicine
Published: December 26, 2023
Heterogeneous expression of ARID1A in colorectal cancer indicates distinguish immune landscape and efficacy of immunotherapy.
Journal: Discover oncology
Published: November 29, 2023
Epigenetics and immunotherapy in colorectal cancer: progress and promise.
Journal: Clinical epigenetics
Published: November 13, 2023
Showing 1-11 of 11
Last Updated: 09/26/2026